When was CellCipher founded?

CellCipher was founded in 2023.

Where is CellCipher located?

CellCipher is headquartered in Chicago, United States.

Is CellCipher a funded company?

CellCipher is a funded company, having raised a total of $***** in its 1st and only funding round.

Where does CellCipher rank among its competitors?

CellCipher ranks 82nd amongst 85 active competitors, of which 12 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Genoskin, which secured $5.4M in Sep, 2025.

Who are the top competitors of CellCipher?

CellCipher's top competitors include Magnitude Biosciences, Genoskin and Reaction Biology. Among them, Genoskin secured the most recent funding round in September, 2025.

CellCipher - 2026 Company Profile & Competitors

CellCipher is an unfunded company based in Chicago (United States), founded in 2023. It operates as a Biotechnology company that provides drug development services. CellCipher has not raised any funding yet. The company has 85 active competitors, including 12 funded and 8 that have exited. Its top competitors include companies like Magnitude Biosciences, Genoskin and Reaction Biology.

Company Details

CellCipher is a biotechnology company that aims to improve the predictive power of preclinical drug development by creating effective and rapid in vitro models of human diseases. The company's platform enables researchers to study human diseases in a controlled and predictable manner, accelerating the discovery of new treatments. By leveraging cutting-edge technologies, CellCipher is poised to revolutionize the way diseases are studied and treated, ultimately improving patient outcomes.

Key Metrics

Founded Year

2023

Location

Chicago, United States

Stage

Unfunded

Ranked

82^nd among 85 active competitors

Similar Companies

Magnitude Biosciences & 94 more

View CellCipher's full profile

CellCipher has not raised any funding rounds yet.

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of CellCipher include Magnitude Biosciences, Genoskin and Reaction Biology. Here is the list of Top 10 competitors of CellCipher, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Magnitude Biosciences 2018, Durham (United Kingdom), Seed	Provider of cell-free in vitro assay for drug discovery companies	$2.6M	Northstar Ventures, Saker Capital & 10 others	58/100
2nd	Genoskin 2011, Toulouse (France), Series A	In vitro human skin models for preclinical toxicity and efficacy testing	$5.4M	OCCTE, Caisse D Epargne & 7 others	53/100
3rd	Reaction Biology 2001, United States, Late Stage	In vitro enzyme activity assays, secializing in kinase & epigenetic HTS and profiling	-	Cobepa, CYwP Funds & 7 others	45/100
4th	ACE Research 2016, Kisumu (Kenya), Unfunded	Provider of contract research organization services for clinical trials	-	-	43/100
5th	Discovery Biomed 2007, Birmingham (United Kingdom), Acquired	Contract research organization	-	NIH, NIDDK & 4 others	39/100
6th	Quantumcyte 2013, Sunnyvale (United States), Seed	Drug assay system to treat cancer	$1.3M	IndieBio, Bayes Ventures	39/100
7th	Radiant Research Services 2009, Bengaluru (India), Acquired	Preclinical in vitro testing and development services	-	-	36/100
8th	Leadgene Biomedical 2013, Tainan (Taiwan), Unfunded	CRO offers invitro drug testing services	-	-	35/100
9th	Orient Gene Biotech 2005, China, Unfunded	Manufactrurer and R&D of in vitro diagnostic reagents	-	-	35/100
10th	American Preclinical 2005, Minneapolis (United States), Acquired	Provider of preclinical services specializing in medical devices and pharmaceuticals	-	-	34/100
82nd	CellCipher 2023, Chicago (United States), Unfunded	Biotechnology company that provides drug development services	-	-	16/100